[HTML][HTML] Mutations of SARS-CoV-2 and their impact on disease diagnosis and severity

L Alquraan, KH Alzoubi, SY Rababa'h - Informatics in Medicine Unlocked, 2023 - Elsevier
Numerous variations of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-
2), including D614G, B. 1.1. 7 (United Kingdom), B. 1.1. 28 (Brazil P1, P2), CAL. 20C …

[HTML][HTML] Coinfections and superinfections associated with COVID-19 in Colombia: A narrative review

D Dueñas, J Daza, Y Liscano - Medicina, 2023 - mdpi.com
The COVID-19 pandemic has had significant impacts on healthcare systems around the
world, including in Latin America. In Colombia, there have been over 23,000 confirmed …

Saliva sampling and its direct lysis, an excellent option to increase the number of SARS-CoV-2 diagnostic tests in settings with supply shortages

J Moreno-Contreras, MA Espinoza… - Journal of Clinical …, 2020 - Am Soc Microbiol
As part of any plan to lift or ease the confinement restrictions that are in place in many
different countries, there is an urgent need to increase the capacity of laboratory testing for …

SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay

V Elizondo, GW Harkins, B Mabvakure… - Emerging microbes & …, 2021 - Taylor & Francis
ABSTRACT COVID-19 is a respiratory illness caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and declared by the World Health Organization a global public …

[HTML][HTML] Exploiting the molecular basis of age and gender differences in outcomes of SARS-CoV-2 infections

D Mercatelli, E Pedace, P Veltri, FM Giorgi… - Computational and …, 2021 - Elsevier
Motivation: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
(coronavirus disease, 2019; COVID-19) is associated with adverse outcomes in patients. It …

Will the emergent SARS‐CoV2 B. 1.1. 7 lineage affect molecular diagnosis of COVID‐19?

JD Ramírez, M Muñoz, LH Patiño… - Journal of Medical …, 2021 - Wiley Online Library
As the coronavirus disease 2019 pandemic keep tackling global public health systems
worldwide. The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV2) genome …

[HTML][HTML] Diagnóstico de laboratorio de COVID-19

P López, R Ballesté, V Seija - Revista Médica del Uruguay, 2020 - scielo.edu.uy
Más de 500 test o pruebas diagnósticas para COVID-19 se están comercializando en el
mercado mundial o se encuentran en avanzada fase de desarrollo. En esta situación, sin …

[HTML][HTML] Bioinformatics accelerates the major tetrad: a real boost for the pharmaceutical industry

T Behl, I Kaur, A Sehgal, S Singh, S Bhatia… - International Journal of …, 2021 - mdpi.com
With advanced technology and its development, bioinformatics is one of the avant-garde
fields that has managed to make amazing progress in the pharmaceutical–medical field by …

Highly conserve sequences in envelope, nucleoprotein and RNA-dependent RNA polymerase of SARS-CoV-2 in nasopharyngeal samples of the COVID-19 patients; …

MS Emadi, S Soltani, B Noori, Z Shateri… - Journal of Cellular & …, 2022 - brieflands.com
: Background: The etiological agent of COVID-19 is SARS-CoV-2. Conversional molecular
methods used for detection of virus in COVID-19 infected patient. This study aimed to …

A study on non-synonymous mutational patterns in structural proteins of SARS-CoV-2

JK Das, S Roy - Genome, 2021 - cdnsciencepub.com
SARS-CoV-2 is mutating and creating divergent variants across the world. An in-depth
investigation of the amino acid substitutions in the genomic signature of SARS-CoV-2 …